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Introduction
The development of the nervous system involves numerous
processes associated with cell motility and the cytoskeleton
such as neuronal migration, growth cone crawling and
extension of filopodia. Although myosins have been widely
hypothesized to be involved in these processes (Jay, 2000;
Mitchison and Kirschner, 1988; Smith, 1988; Suter and
Forscher, 2000), their identities and roles are not yet clear.
Myo10 (myosin-X) is a recently discovered myosin that
localizes to the tips of filopodia, undergoes a novel form of
motility within filopodia and leads to increased filopodia when
overexpressed (Berg and Cheney, 2002; Sousa and Cheney,
2005). Little is known about Myo10 in brain or neurons,
although its mRNA has been reported to increase sevenfold
during nerve regeneration (Tanabe et al., 2003). Myo10 also
binds to several molecules known to be important in neuronal
development, including calmodulin (Homma et al., 2001),
phosphatidylinositol (3,4,5)-trisphosphate [PtdIns(3,4,5)P3]
(Isakoff et al., 1998), microtubules (Weber et al., 2004), and -
integrins (Zhang et al., 2004). Although these properties
suggest that Myo10 has important roles in the nervous system,
the initial northern and immunoblots for Myo10 indicated that
brain expresses an uncharacterized, short form of Myo10 (Berg
et al., 2000). Determining the nature of this short form of
Myo10 is thus an essential first step in investigating Myo10’s
role in neurons; we report here the identity of this isoform as
well as the developmental regulation, localization and
dynamics of Myo10 in brain and neurons.
Myo10 is a vertebrate-specific member of a superclass of
myosins, whose tails are characterized by the presence of
myosin tail homology 4 (MyTH4) and band-
4.1/ezrin/radixin/moesin (FERM) domains (Berg et al., 2001;
Sousa and Cheney, 2005). MyTH-FERM myosins appear to
mediate membrane-cytoskeleton interactions underlying
processes such as adhesion (Tuxworth et al., 2001; Zhang et
al., 2004), phagocytosis (Cox et al., 2002; Titus, 1999), and
formation of filopodia and related structures (Belyantseva et
al., 2003; Berg and Cheney, 2002; Tuxworth et al., 2001).
Although Myo10 is expressed at relatively low levels, it
appears to be the MyTH-FERM myosin expressed in most
vertebrate cells (Berg et al., 2000).
The approximately 240 kDa heavy-chain of full-length
Myo10 can be divided into  head, neck and tail (Berg et al.,
2000; Yonezawa et al., 2000). The head binds to actin,
Although Myo10 (myosin-X) is an unconventional myosin
associated with filopodia, little is known about its isoforms
and roles in the nervous system. We report here that, in
addition to full-length Myo10, brain expresses a shorter
form of Myo10 that lacks a myosin head domain. This
‘headless’ Myo10 is thus unable to function as a molecular
motor, but is otherwise identical to full-length Myo10 and,
like it, contains three pleckstrin homology (PH) domains, a
myosin-tail homology 4 (MyTH4) domain, and a
band-4.1/ezrin/radixin/moesin (FERM) domain.
Immunoblotting demonstrates that both full-length and
headless Myo10 exhibit dramatic developmental regulation
in mouse brain. Immunofluorescence with an antibody that
detects both isoforms demonstrates that Myo10 is
expressed in neurons, such as Purkinje cells, as well as non-
neuronal cells, such as astrocytes and ependymal cells.
CAD cells, a neuronal cell line, express both full-length and
headless Myo10, and this endogenous Myo10 is present in
cell bodies, neurites, growth cones and the tips of filopodia.
To investigate the dynamics of the two forms of Myo10 in
neurons, CAD cells were transfected with GFP constructs
corresponding to full-length or headless Myo10. Only full-
length Myo10 localizes to filopodial tips and undergoes
intrafilopodial motility, demonstrating that the motor
domain is necessary for these activities. Live cell imaging
also reveals that full-length Myo10 localizes to the tips of
neuronal filopodia as they explore and interact with their
surroundings, suggesting that this myosin has a role in
neuronal actin dynamics.
Supplementary material available online at
http://jcs.biologists.org/cgi/content/full/119/1/184/DC1
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185Myo10 in brain and neurons
hydrolyzes ATP and moves towards the barbed end of the actin
filament (Homma et al., 2001). The neck consists of three IQ
motifs, each of which provides a binding site for calmodulin
or a calmodulin-like light-chain (Homma et al., 2001; Rogers
and Strehler, 2001). The tail begins with a segment predicted
to form a coiled coil, which suggests that the Myo10 heavy-
chains can dimerize. The coiled coil is followed by three PEST
(proline-, glutamate-, serine- and threonine-rich) regions that
provide proteolytic cleavage sites and may allow the motor to
be decoupled from the remainder of the tail (Berg et al., 2000).
The Myo10 tail is unique among myosins because it includes
three pleckstrin homology (PH) domains and can bind
PtdIns(3,4,5)P3 (Isakoff et al., 1998; Mashanov et al., 2004).
This suggests that Myo10 functions downstream of
phosphoinositide 3-kinase (PI 3-kinase), an important
regulator of cell motility. The Myo10 tail also includes a
MyTH4 domain that can bind to microtubules, thus allowing
Myo10 to link actin filaments and microtubules (Weber et al.,
2004). The Myo10 heavy-chain ends in a FERM domain that
can bind to the cytoplasmic domain of 1-, 3- or 5-integrin
(Zhang et al., 2004), which suggests Myo10 can act as a
motorized clutch to link cell adhesion molecules to the actin
cytoskeleton.
Myo10 exhibits a striking localization to the tips of the
slender actin-based extensions known as filopodia (Berg and
Cheney, 2002; Berg et al., 2000). Filopodia appear to act as
cellular sensors in processes such as growth cone guidance
(Davenport et al., 1993), angiogenesis (Gerhardt et al., 2003)
and cell migration (Rorth, 2003). Filopodia contain a core of
bundled actin filaments and are surrounded by a cylindrical
sheath of plasma membrane (Svitkina et al., 2003). Actin
polymerization occurs at the barbed ends of the actin filaments,
which are located at the tip of the filopodium. Since the actin
filaments in filopodia undergo retrograde (rearward) flow, it is
the balance between the rate of actin polymerization at the
filopodial tip and the rate of retrograde flow that determines
whether a given filopodium extends or retracts (Mallavarapu
and Mitchison, 1999). In addition to localizing at the tips of
filopodia, full-length Myo10 undergoes forward and rearward
movements within filopodia that we term intrafilopodial
motility (Berg and Cheney, 2002). We hypothesize that the
forward movements are powered by the Myo10 motor domain
moving towards the barbed ends of filopodial actin filaments,
whereas the rearward movements result from a rigor-like
binding to actin filaments that undergo retrograde flow. Full-
length Myo10 can also stimulate the formation or stabilization
of filopodia because, when overexpressed, it increases the
number and length of filopodia in COS-7 cells (Berg and
Cheney, 2002). This effect is not observed with an HMM-like
Myo10 construct or a tail-alone construct (Berg and Cheney,
2002).
We report here that, brain and neuronal cells express a
headless form of Myo10, which lacks nearly all of the myosin
motor domain, and is thus unable to function as a molecular
motor. We also show that both full-length and headless Myo10
exhibit dramatic developmental regulation in brain. In addition,
we report the first immunolocalization of Myo10 in brain, and
use CAD cells as a model system to investigate the dynamics
of headless and full-length Myo10 in a neuronal cell line.
These experiments reveal that although headless Myo10 does
not localize to neuronal filopodia or undergo intrafilopodial
motility, full-length Myo10 does localize to the tips of filopodia
and can undergo several intriguing forms of motility in
neuronal cells.
Results
Identification of a headless myosin in brain
Although previous research indicated that brain expresses a
short form of Myo10, the structure of this short form was
unknown (Berg et al., 2000). A human multiple tissue northern
blot, probed with sequences consisting primarily of 3 UTR
from full-length Myo10, indicated that the short form of
Myo10 expressed in brain is ~2 kb shorter than the full-length
(~9 kb) mRNA expressed in other tissues (Berg et al., 2000)
(Fig. 1). Immunoblots of bovine tissues were consistent with
this finding and indicated that the short form in brain is ~60-
70 kDa smaller than the ~240 kDa full-length Myo10 (Berg et
al., 2000) (Fig. 2) The short form reacted with two different
antibodies to bovine Myo10, one made against  amino acids
(aa) 1-952 and another against aa 1639-1798. The short form
of Myo10 is thus expected to include a sequence from both
these regions as well as a sequence from the 3 UTR, while
being ~60-70 kDa smaller than full-length Myo10.
To determine the structure of the short form of Myo10, we
first generated an intron-exon map of the human MYO10 gene
by aligning a full-length human MYO10 cDNA
(NM_012334) with genomic sequence (Fig. 1A). We then
searched the National Center for Biotechnology Information
(NCBI) database to identify expressed sequences tags
(ESTs), potentially encoding the short form of Myo10. We
found a human EST from fetal brain [gi:5552940/AI878891;
nucleotide (nt) 191-568] that matched perfectly with nt 2152-
2529 of the full-length MYO10 cDNA. The matching
sequence is located at the start of the MYO10 exon that begins
with M644. However, the first part of the EST (nt 34-190) did
not match this region but instead matched perfectly with a
genomic sequence for the full-length transcript, located ~30
kb upstream of the exon encoding M644 in the middle of a
very large (~43 kb) intron. This suggests that, the short form
of Myo10 results from the use of an alternative promotor,
which transcribes an alternative exon encoding a 5 UTR
unique to the short form. This 5 UTR is spliced to the exon
beginning with M644, a methionine predicted by GENSCAN
to function as a translation start site (Burge and Karlin, 1997).
Since this short transcript would lack most of the Myo10
motor domain but include the rest of Myo10 (aa 644-2058),
we refer to it as headless Myo10. Consistent with the data
obtained from northern blots, the headless Myo10 transcript
shares the same 3 UTR as the full-length Myo10, but is ~2
kb shorter. Consistent with previous immunoblotting data,
translation that starts at M644 results in a protein of 163,567
Da (1415 aa), which overlaps with both of the fusion protein
constructs that were used to make the initial antibodies
against Myo10.
Northern blot and PCR evidence for the headless Myo10
transcript
To test whether the short form of Myo10 observed in
northern blots corresponds to this headless transcript, we
reprobed the human-multiple-tissue northern blot with the 5
UTR specific to the headless form. As predicted, this probe












larger (~9 kb) full-length transcript (Fig. 1). In addition,
when the blot was reprobed with a sequence from the head
domain, we detected only the full-length (~9 kb) band
and not the shorter transcript. To further confirm the
existence of headless Myo10, we performed PCR of brain
cDNA with a forward primer specific for the 5 UTR of the
headless transcript and a reverse primer from an exon that is
shared by both transcripts. These primers would be 377 nt
apart in the headless but are ~33,000 nt apart in genomic
sequence. As expected from transcription of headless
Myo10, a band of ~377 nt was amplified. Cloning and
sequencing of this PCR product showed that it perfectly
matches the 5 UTR and the coding sequence predicted for
headless Myo10.
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Additional EST evidence for headless Myo10 in human
and mouse
Recent database searches have revealed at least eight additional
human ESTs that correspond to the headless Myo10 transcript
[gi:52240826 and gi:52278375 from brain, gi:52103381 from
fetal brain, gi:52087137 from corpus callosum, gi:52194716
and gi52191621 from the  glioma cell line KG-1-C,
gi:24044427 from a teratocarcinoma cell line, and gi:47334466
from embryonic stem (ES) cells]. The initial, automated
analysis of the mouse genome also predicted the existence of
an equivalent transcript for headless Myo10 in mouse
(sequence record XM_192774), and there are at least six
mouse ESTs that correspond to the 5 UTR and initial coding
sequence of the headless Myo10 transcript [gi:34584306 from
Fig. 1. Brain expresses a headless form of Myo10. (A) Schematic map of the human Myo10 gene and bar diagrams of the full-length and
headless Myo10 transcripts. The headless transcript begins with an alternate exon (gray) that encodes a 5 UTR specific to headless Myo10.
Splicing of this 5 UTR to the exon that begins at M644 of full-length Myo10, results in a headless transcript lacking the first 643 aa of full-
length Myo10. Major domains of the Myo10 protein are indicated by colored boxes, vertical lines on the gene map represent exons. The
horizontal red lines indicate the locations of the probes used for northern blotting. (B) Multiple-tissue northern blot incubated with three
different Myo10 probes. The blot was originally incubated with a probe targeting the 3 UTR common to both transcripts (right) and detected
both a ~9 kb band (upper arrowhead) in non-brain tissues and a smaller ~7 kb band (lower arrowhead) in brain  (Berg et al., 2000). The blot was
then stripped and reprobed with a sequence from the 5 UTR of the headless transcript (middle), which detected a ~7 kb band in brain but not
the full-length ~9 kb band in other tissues. The blot was then stripped and reprobed a final time with a sequence from the head domain (left). In
addition to the ~7 kb band in brain, the headless probe appears to react non-specifically with a faint band in tissues such as liver that is slightly
larger than the ~9 kb band corresponding to full-length Myo10. (C) Sequence alignment of human EST AI878891 with full-length Myo10
cDNA (NM_012334) show the 5 UTR specific to the headless form (capitalized nucleotides) as well as the initial protein-coding exons of the
headless form and their perfect match to the full-length Myo10 exon beginning at M644. Exon boundaries are indicated by vertical dotted lines
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newborn brain, gi:26467095 from visual cortex, gi:29353457
from prenatal brain, gi:22497702 from embryonic day 12.5
(E12.5) whole brain, gi:16458330 from whole E8 embryo, and
gi:27328064 from neuronal stem cells]. Finally, analysis of the
Riken full-length enriched cDNA collection indicates that the
mouse clone ri:5730439K04 from E8 mouse embryo has a 5-
sequence-read (PXB0064413a/BB618862) that perfectly
matches the first ~500 nt of the predicted headless transcript
and a 3-sequence-read (PXB00644K13b/AV296136) that
perfectly matches ~600 nt of the 3 UTR shared by both full-
length and headless Myo10. Together, these data from
sequence analysis, northern blotting, PCR and immunoblotting
thus demonstrate the existence of headless Myo10 in both
human and mouse brain.
Headless and full-length Myo10 are developmentally
regulated in brain
To determine whether Myo10 is developmentally regulated, we
generated an antibody (no. 3568) to the coiled-coil region of
mouse Myo10, and used it to blot samples from the cerebri and
cerebelli of mice, ranging in age from postnatal day 1 (P1) to
adult. Since the headless transcript contains the coiled-coil
region, this antibody was predicted to react with both full-
length and headless Myo10. As expected, the new antibody
reacted with the ~240 kDa full-length and the ~165 kDa short
form in immunoblots of mouse brain (Fig. 2). In the mouse
cerebrum, Myo10 exhibited striking developmental regulation,
with both forms showing a peak of expression between P5 and
P15, and greatly decreased expression in the adult. A different
pattern of expression was observed in the mouse cerebellum,
where full-length Myo10 was expressed much more
prominently than the short form. In addition, expression of full-
length Myo10 continued to increase during postnatal
development of the mouse cerebellum, with adult cerebellum
exhibiting the highest level of expression.
Myo10 is expressed in neurons and non-neuronal cells
Although brain clearly expresses both full-length and headless
Myo10, there was no data on the immunolocalization of
Myo10 in brain and it was not clear whether Myo10 is
expressed in both neurons and glia or whether it localizes
selectively to axons as opposed to dendrites. We therefore
performed immunofluorescence localization experiments on
frozen sections of mouse brain with the new antibody against
mouse Myo10. In adult mouse cerebellum, the brightest
staining for Myo10 was observed in the cell bodies and
dendrites of Purkinje cells (Fig. 3A-F), consistent with our
previous data from in-situ hybridization (Berg et al., 2000). In
optimally oriented sections, faint staining of Purkinje-cell
axons was sometimes observed (not shown). In general,
however, white matter showed relatively little Myo10 staining
(Fig. 3A). The Myo10 antibody also stained the processes of
glial cells, such as the Bergmann glia, as shown by double
labeling with the astrocytic marker glial fibrillary acidic protein
(GFAP) (Fig. 3G-L). Although antibody no. 3568 detects both
full-length and headless Myo10 in immunoblots, it is likely that
the immunostaining in adult mouse cerebellum is due to full-
length Myo10, because this is the only form that was detected
in immunoblots of adult mouse cerebellum (Fig. 2B).
Consistent with the relatively low level of Myo10 expression
detected in immunoblots of adult mouse cerebrum, only faint
Myo10 staining was observed in the parenchyma of this tissue
(not shown). Sections from cerebrum that included the
ventricles, however, revealed that Myo10 stains ependymal
cells brightly (Fig. 3M). These cells form a single layer of
epithelial cells that line the ventricles and are of special interest
because they have been suggested to function as neuronal stem
cells (Johansson et al., 1999). The astrocytes subjacent to the
ependymal cells also show some Myo10 staining, as shown by
the colocalization with GFAP (Fig. 3N,O). Brain sections
incubated with a non-immune control generated little or no
background-staining under these conditions (data not shown).
Both isoforms of Myo10 are expressed in CAD cells
To investigate the localization and dynamics of Myo10 in
neurons, we used CAD cells as a neuronal cell culture model.
CAD cells are a transfectable mouse cell line that can be
induced to differentiate into catecholaminergic neurons by
serum withdrawal (Qi et al., 1997). To determine whether CAD
cells express endogenous Myo10, we first immunoblotted SDS
lysates of CAD cells with the antibody against mouse Myo10.
Consistent with the widespread expression of full-length
Myo10 in mammalian cells, the band of the ~240 kDa full-
length Myo10 was detected in both undifferentiated and
differentiated CAD cells (Fig. 2C). The band of the ~165 kDa
headless Myo10 was also detected in both types of CAD cells.
Similar results were obtained in immunoblotting experiments
with other cell lines that can be differentiated into a neuronal
phenotype such as PC-12 pheochromocytoma cells and B35
neuroblastoma cells (data not shown), suggesting that headless
Myo10 is expressed at very early stages of neuronal
development.
Fig. 2. Myo10 expression in brain is developmentally regulated.
Western blot of whole cerebri (A) or cerebelli (B) from mice at
postnatal days 1 to adult (P>45) were lysed in SDS sample buffer
and immunoblotted with antibody no. 3568 against mouse Myo10.
Both full-length- (~240 kDa) and headless-Myo10 (~164 kDa) are
expressed in mouse cerebrum where they show clear developmental
regulation, with a peak of expression between postnatal days 5-15.
Cerebellum from mouse shows a different pattern of Myo10
expression, with prominent and increasing levels of full-length
Myo10 expression throughout development. (C) Full-length and
headless Myo10 (arrowheads) are detected by immunoblotting in
undifferentiated CAD cells as well as in CAD cells differentiated












Undifferentiated CAD cells form
prominent lamellipodia with short filopodia
along their leading edge (Fig. 4A,B). These
filopodia give rise to large bundles of actin
or ‘rootlets’ that extend deep into the
lamellipodium. CAD cells thus have an
actin organization somewhat similar to that
of growth cones from Aplysia (Lin et al.,
1997) and Helisoma (Zhou et al., 2002).
CAD cells differentiated by serum
withdrawal for ~2 days acquire a neuronal
phenotype and form neurites, growth
cones, and numerous long filopodia (Fig.
4C,D). Immunostaining in undifferentiated CAD cells with
antibody no. 3568 revealed that endogenous Myo10 localizes
at the tips of short filopodia but is also present at the plasma
membrane and cell body (Fig. 4A). In differentiated CAD cells,
endogenous Myo10 clearly localizes at the tips of neuronal
filopodia, but also exhibits a more diffuse localization in
neurites and cell bodies (Fig. 4C). A similar pattern of
localization was seen in cultured primary rat neurons
(supplementary material, Fig. S1). Control cells stained with
non-immune IgG show little or no background under these
staining conditions (Fig. 4B,D).
Full-length, but not headless Myo10, localizes to the tips
of neuronal filopodia
Although the experiments described above revealed the
subcellular localization of endogenous Myo10 in neurons, they
did not allow us to distinguish between the localization of
headless and full-length Myo10 because the antibody reacts
Journal of Cell Science 119 (1)
with both forms. To investigate the functional differences
between these two forms of Myo10, we expressed GFP
constructs corresponding to full-length and headless Myo10 in
CAD cells. In undifferentiated CAD cells, full-length GFP-
Myo10 localizes to the tips of the short filopodia at the edge
of the lamella (Fig. 5A). Headless GFP-Myo10 does not
localize to filopodial tips and instead exhibits a more diffuse
localization to the lamellipodial plasma membrane and cell
body (Fig. 5B).
In differentiated CAD cells, full-length GFP-Myo10
localizes to the tips of neuronal filopodia, although it is also
present in neurites and cell bodies (Fig. 5C). Headless GFP-
Myo10 does not localize to the tips of neuronal filopodia, and
instead exhibits a more diffuse localization along neurites and
cell bodies (Fig. 5D). The localization of full-length GFP-
Myo10 to the tips of filopodia is particularly striking at early
stages of differentiation, when numerous filopodia are present
(Fig. 5E). It should also be noticed that GFP-Myo10 localizes
Fig. 3. Immunolocalization of Myo10 in mouse
brain. (A-C) Sagittal section from the
cerebellum of an adult mouse double-labeled
for Myo10 and calbindin, a marker for Purkinje
cells. The cell bodies of Purkinje cells (PL) and
their dendrites in the molecular layer (ML) are
brightly stained by Myo10. Myo10 stains the
granule-cell layer (GL) more faintly, and the
cerebellar white matter (WM) shows little
staining. (D-F) A similar section of the
molecular layer at higher magnification shows
staining for Myo10 in the dendrite (arrow in E)
of a Purkinje cell. (G-I) Sagittal section from
the cerebellum of an adult mouse double-
labeled for Myo10 and GFAP, a marker for
Bergmann glia and other astrocytes. (J-L) A
similar section of the molecular layer at higher
magnification showing that Myo10 staining is
also present in the processes of Bergmann glia
(arrow in K). (M-O) Sagittal section from the
cerebrum of an adult mouse double-labeled for
Myo10 and GFAP showing staining of the
ventricular zone (VZ) and subventricular zone
(SVZ). Although the parenchyma of the adult
mouse cerebrum shows relatively faint Myo10
staining, the ependymal cells lining the
ventricle show bright Myo10 staining. The
subjacent subventricular astrocytes marked by
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to the tips of filopodia-like structures at sites of cell-cell contact
in both undifferentiated (Fig. 6A) and differentiated CAD cells
(Fig. 6B; see also supplementary material Movie 5).
Live-cell imaging of Myo10 dynamics in undifferentiated
CAD cells
To simultaneously visualize the dynamics of actin and Myo10,
undifferentiated CAD cells were transfected with CFP--actin
and GFP-Myo10. As seen in Figs 4-6, undifferentiated CAD
cells have a lamellipodial morphology quite different from the
HeLa cells used in our previous live-cell imaging experiments
(Berg and Cheney, 2002). Like growth cones, the lamellipodia
of these cells exhibit prominent retrograde flow
(supplementary material, Movies 1, 2). As expected, live-cell
imaging shows that both full-length Myo10 and the largely
tailless HMM-Myo10 construct localize to the tips of
filopodia. Live-cell imaging also reveals that the tip puncta
formed by these constructs are occasionally ‘released’ from
the tip and move rearward through the lamellipodium, a
behavior that was especially prominent with HMM-Myo10
(supplementary material, Movie 1). These movements
demonstrate for the first time that puncta of Myo10 are able
to move rearward within lamellipodia along filopodial
‘rootlets’. GFP-Myo10 moved rearward at the same rate as the
CFP-actin, consistent with the hypothesis that rearward
movement of Myo10 results from its binding to actin filaments
that are undergoing retrograde flow. The observation that
HMM-Myo10 exhibits localization and movements similar to
those of full-length Myo10 also supports this model. Headless
Myo10 exhibits a relatively diffuse distribution and does not
localize to filopodial tips or undergo intrafilopodial motility
(supplementary material, Movie 2).
Myo10 can undergo lateral movements along the
leading edge
In addition to radial movements along filopodial actin bundles,
we also discovered that Myo10 tip puncta can undergo lateral
movements along the leading edge of CAD cell lamellipodia.
Interestingly, these lateral movements sometimes lead tip
puncta to collide and fuse with other puncta along the leading
edge. Lateral fusion events occasionally appeared to trigger
Fig. 4. Subcellular localization of endogenous Myo10 in CAD cells.
(A) In undifferentiated CAD cells, Myo10 shows a clear localization
to the leading edge as well as a more diffuse localization in central
cytoplasm. (B) Undifferentiated CAD cells stained with a non-
immune control antibody show little or no staining. (C) After ~2
days of serum withdrawal to induce CAD-cell differentiation into a
neuronal phenotype, Myo10 staining is observed in cell bodies,
neurites, the edges of growth cones and the tips of neuronal
filopodia. (D) Differentiated CAD cells stained with a non-immune
control antibody show little or no staining. Myo10 antibody no. 3568
was used to stain Myo10 (green) and rhodamine-phalloidin was used
to label F-actin (red).
Fig. 5. Full-length Myo10, but not headless Myo10, localizes to the
tips of filopodia when transfected into CAD cells. (A) In
undifferentiated CAD cells, full-length GFP-Myo10 (green) localizes
to the tips of the short filopodia along the leading edge. (B) Headless
GFP-Myo10 does not localize to filopodial tips and instead shows a
more diffuse localization to the cell membrane and the central
portion of undifferentiated CAD cells. (C) In CAD cells induced to
differentiate into a neuronal phenotype, full-length GFP-Myo10
localizes to neurites as well as the tips of neuronal filopodia.
(D) Headless GFP-Myo10 localizes primarily to the soma and
neurites of differentiated CAD cells and does not localize to the tips
of filopodia. (E) High-magnification images showing localization of
full-length GFP-Myo10 to the tips of filopodia in CAD cells at early
stages of differentiation. Notice that the filopodia frequently clump
together at their tips. Cells were double-labeled with rhodamine-












the tip puncta to move rearward, a behavior that was especially
prominent with HMM-Myo10 (supplementary material,
Movie 1). The lateral movements of small tip puncta and their
fusion with larger puncta are clearly illustrated by
kymographic analysis of the leading edge from a relatively
Journal of Cell Science 119 (1)
stationary CAD cell transfected with full-length GFP-Myo10
(Fig. 7; supplementary material, Movie 3). The dendritic
pattern of this kymograph demonstrates that, although the
larger tip puncta appear to be relatively stable, smaller tip
puncta continuously appear along the leading edge and move
laterally until they collide and fuse with brighter tip puncta.
This indicates that the leading edge is continuously generating
new tip puncta and that these move laterally until they fuse
with larger and apparently more stable tip puncta.
Dynamics of Myo10 in differentiating CAD cells
Full-length GFP-Myo10 also exhibits several intriguing
forms of movement in CAD cells differentiated to a more
neuronal phenotype. The lamellipodium of the transfected
CAD cell seen on the left side of Movie 4 in the
supplementary material, for example, shows several examples
of Myo10 tip puncta undergoing rearward movement in
lamellipodia. Although some of these rearward movements
are due to translocation of an entire filopodium, in other cases
puncta of Myo10 move rearward along a filopodial rootlet.
We also discovered that puncta of GFP-Myo10 occasionally
undergo ‘rocketing’ movements within the cell body. This is
seen most clearly with the very bright spot of GFP-Myo10 on
the left side of Movie 4 in the supplementary material. After
moving rearward, this spot of GFP-Myo10 spirals forward at
the tip of an actin-rich intrapodium. Other examples of
rocketing intrapodia with Myo10 at their tips can also be seen
in this region. GFP-Myo10 can also undergo both forward
and rearward intrafilopodial motility in neuronal filopodia
and retraction fibers (supplementary material, Movie 4).
Movie 5 in the supplementary material demonstrates that
GFP-Myo10 is present at the tips of neuronal filopodia when
they extend, retract and interact with a neurite from a
nontransfected cell. As expected, if the tip localization and
movements are due to Myo10 motor activity, the largely
tailless GFP-HMM-Myo10 construct exhibits similar tip
localization and movements (supplementary material, Movie
6). The very active dynamics of GFP-Myo10 in neuronal
filopodia on the cell body, neurite and growth cone are
illustrated in supplementary material Movie 7, where Myo10
is associated with numerous filopodia as they extend, retract
and undergo intrafilopodial motility.
Fig. 6. Full-length Myo10 localizes to sites of cell-cell contact.
(A) In undifferentiated CAD cells, GFP-Myo10 (green) is present at
the tips of short filopodia-like structures at sites of cell-cell contact.
The panels on the right shows high-magnification views of the inset.
(B) GFP-Myo10 is also present at the tips of filopodia at sites of cell-
cell contact in differentiated CAD cells. The panels on the right show
high-magnification views of the inset and illustrate that Myo10 is
present at the tips of filopodia that are contacting neurites. Cells were
double-labeled for F-actin by staining with rhodamine-phalloidin
(red). Although under the exposure settings used here some filopodia
appear only faintly labeled for F-actin relative to the much thicker
neurites and cell bodies, longer exposures indicate that all of the
filopodia contain F-actin.
Fig. 7. Puncta of Myo10 can move laterally along the leading edge and fuse with
one another. (A) Fluorescence image of an undifferentiated CAD transiently
transfected with full-length GFP-Myo10 showing 17 relatively large puncta of GFP-
Myo10 (labeled a-q) at the tips of filopodial bundles along the leading edge.
(B) Outline of the leading-edge region of this cell that was imaged for 12 minutes
and then displayed as a kymograph to highlight movements along the lateral edge.
(C) Kymograph illustrating the movements of puncta of Myo10 along the leading
edge. Although the larger
Myo10 puncta maintained
relatively stable positions
along the leading edge,
smaller Myo10 puncta
tended to move laterally
along the leading edge until
they collided and fused with
larger puncta, thus
generating a kymograph
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Discussion
Discovery of a headless Myo10 in brain
The data presented here from sequence analysis, northern blots,
PCR and immunoblots demonstrate that brain expresses a
headless form of Myo10. Headless Myo10 thus lacks the
defining element of a myosin and is unable to function as a
molecular motor. Although no other headless myosins have
been characterized in vertebrates, there are two examples of
such proteins in invertebrates. The use of an alternative
promotor in Drosophila melanogaster muscle myosin leads to
the transcription of a headless myosin, known as myosin
related protein (MRP) (Standiford et al., 1997). This protein
consists almost entirely of coiled coil and can co-assemble into
thick filaments. Similarly, use of an alternative promotor in a
molluscan myosin II gene leads to the transcription of catchin,
a rod-like protein found in catch muscles (Yamada et al., 2000).
In both of these examples, the exons that contain initiation
methionine codons are found within large introns of the
corresponding muscle myosin genes, and both proteins contain
unique N-terminal domains. Although headless Myo10 does
not appear to contain any unique N-terminal protein sequence
and is not predicted to form a rod-like protein, these examples
do set a precedent for the use of alternative transcription start
sites to generate headless myosins.
Consistent with the northern blotting data presented here,
Yonezawa et al. detected a ~9 kb full-length Myo10 transcript
in northern blots of mouse tissues probed with head domain
sequence (Yonezawa et al., 2000). However, they also reported
as data not shown an additional transcript at ~7 kb, when the
blots were probed with sequence from the tail domain.
Although the headless transcript we describe here is the first
alternative Myo10 transcript characterized to date, the large
size of Myo10 raises the possibility that other alternative
transcripts may also be produced. Indeed, database searches
reveal a 5880 nt cDNA from adult mouse brain
(gi:28972398/mKIAA0799) and an EST from embryonic
mouse head (gi:46863450), indicating the existence of a
slightly shorter form of headless Myo10. This slightly shorter
transcript includes the same 5 UTR found in the headless
Myo10 described above, and is identical to it except for
skipping the first two protein-coding exons. Translation of this
slightly shorter transcript from M747 would yield a 151,551 Da
(1325 aa) headless Myo10 that includes the IQ motifs and all
of the other tail domains found in the headless Myo10
described above.
Based on headless Myo10’s domain structure of three IQ
motifs, a short segment of coiled coil, three PEST regions,
three PH domains, a MyTH4 domain and a FERM domain, we
predict that – like full-length Myo10 – headless Myo10 has
calmodulin-like light-chains, probably forms a dimer, is
susceptible to calpain cleavage, and can bind to
PtdIns(3,4,5)P3, microtubules and integrins. A possible role for
headless Myo10 is to act as a natural ‘dominant negative’ to
suppress or spatially limit the activities of full-length Myo10
in neurons. In this regard it should be noticed that a Myo10-
tail construct consisting of the PH, MyTH4 and FERM
domains appears to act as a dominant-negative inhibitor of
phagocytosis in macrophages (Cox et al., 2002). It is also
possible that the combination of PH, MyTH4 and FERM
domains found in headless Myo10 has functions of its own that
are independent of the Myo10 motor domain. Consistent with
this possibility, humans express three proteins, MAX-1,
PLEKHH2 and FLJ21019, that have domain structures similar
to the tail of Myo10 (Fig. 8). Although little is known about
PLEKHH2 and FLJ21019, Caenorhabditis elegans motor axon
guidance-1 (MAX-1) is required for proper guidance of motor
neurons through the netrin signaling pathway (Huang et al.,
2002).
Expression and localization of Myo10 in brain
Our immunofluorescence experiments clearly show that
Myo10 is expressed in neurons, such as Purkinje cells, and in
non-neuronal cells, such as astrocytes and ependymal cells.
Within Purkinje cells, anti-Myo10 stains cell bodies, dendrites
Fig. 8. Diagrams of proteins with domain structures similar to the tail of Myo10. Illustrated are the domain structures of human proteins that are
structurally similar to headless Myo10. Domain predictions were based on the NCBI/CDD and/or PFAM servers. Regions predicted to form
coiled coils by the PAIRCOIL server are indicated by ‘CC’. Arrows indicate protein identity in %. Although the C-terminal portion of
FLJ21019 was not recognized as a FERM domain by CDD or PFAM, database searches with FLJ21019 show that it shares 32% protein identity
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and axons. This staining is almost certainly due to full-length
Myo10 because only full-length Myo10 was detected in adult
cerebellum. The detection of headless Myo10 in cerebrum but
not most other tissues suggests that headless Myo10 is
expressed primarily in neurons, a conclusion that is also
supported by our immunoblots, showing that neuronal cell
lines, such as CAD cells express headless Myo10. Further
supporting this conclusion is the observation that we have not
detected the ~165 kDa headless Myo10 band in a variety of
non-neuronal cell lines we have tested by immunoblotting,
including HeLa, HEK 293, COS-7, A-431, Swiss 3T3, HL-60,
RAW 264.7 and LLC-PK1 cells, all of which do express full-
length Myo10.
Developmental regulation of Myo10
The immunoblotting experiments reported here reveal that
Myo10 exhibits dramatic developmental regulation in brain. In
mouse cerebrum, full-length and headless Myo10 appear to be
expressed at roughly similar levels and exhibit a peak of
expression between postnatal days 5-15, with much lower
expression levels in the adult. Although many different
developmental processes occur during this early postnatal
period – including process outgrowth and synapse formation –
the close link between full-length Myo10 and filopodia
suggests that Myo10 is associated with the numerous filopodia
generated at this time (Fiala et al., 1998; Ziv and Smith, 1996),
when pyramidal neurons are estimated to generate 50,000
dendritic filopodia per day (Portera-Cailliau et al., 2003).
Although the roles of myosins in brain are still being worked
out (Brown and Bridgman, 2004), Myo1b/myosin-I localizes
to growth cones (Lewis and Bridgman, 1996), non-muscle
myosin-II is required for normal growth cone motility and
outgrowth (Brown and Bridgman, 2003; Wylie and Chantler,
2001), and Myo16/Myr8 exhibits a dramatic peak of
expression in the first two weeks after birth (Patel et al., 2001).
For Myo10, it is important to notice that the expression pattern
in cerebrum differs significantly from the one in cerebellum,
which expresses relatively little headless Myo10. In addition,
expression of full-length Myo10 increases throughout
cerebellar development and is highest in adult mice. This
expression of Myo10 in adult cerebellum is consistent with our
previous in-situ hybridization data (Berg et al., 2000) and our
current immunolocalization data in Purkinje cells.
The developmental regulation of Myo10 in brain is
particularly interesting given the recent report that Myo10 is
one of approximately 20 genes whose expression increased
sevenfold or more after a peripheral nerve crush (Tanabe et al.,
2003). Northern blots of developing mouse dorsal-root ganglia
showed that both the full-length ~9 kb transcript and the shorter
~7 kb transcript were expressed at postnatal day 3, and then
declined to lower levels in the adult (Tanabe et al., 2003). When
DRG neurons were actively regenerating 7 days after a
crush injury, however, both transcripts were significantly
upregulated. Together with our results, these data suggest that
Myo10 probably plays important roles in the development and
regeneration of the nervous system.
Localization of Myo10 in CAD cells
The localization data in CAD cells show that endogenous
Myo10 exhibits a striking localization to the tips of filopodia
in undifferentiated CAD cells. In addition to tip staining,
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however, endogenous Myo10 in undifferentiated CAD cells
also exhibits a more diffuse staining of the cell body and
cytoplasm. Since transfection of these cells with full-length
GFP-Myo10 yields a filopodial-tip pattern, whereas
transfection with headless GFP-Myo10 yields a more diffuse
localization to the cell body and cytoplasm, we interpret the
staining pattern of endogenous Myo10 as the sum of filopodial-
tip staining due to full-length Myo10 and a more diffuse
staining due largely to headless Myo10.
Immunofluorescence in differentiated CAD cells and rat
cortical neurons demonstrated that Myo10 is present at the tips
of neuronal filopodia, as well as in growth cones, neurites and
neuronal cell bodies. Transfection experiments demonstrated
that only full-length Myo10 localizes to the tips of filopodia,
whereas headless Myo10 exhibits a more diffuse localization
in neurites and cell bodies. This demonstrates that the Myo10
motor is necessary for tip localization in neuronal filopodia and
supports the hypothesis that Myo10 uses its own motor activity
to transport itself to the tips of filopodial actin bundles.
Dynamics of Myo10 in CAD cells
Live-cell imaging in CAD cell also reveals several important
findings related to the movements and functions of Myo10.
First, full-length Myo10, but not headless Myo10, localizes to
the tips of neuronal filopodia and can undergo intrafilopodial
motility. Second, the largely tailless HMM-Myo10 construct
behaves similar to full-length Myo10 in that it localizes to the
tips of neuronal filopodia and can undergo rearward
movements on filopodial actin bundles. This demonstrates that
the Myo10 head, neck and coiled coil are sufficient to allow
rearward movement, consistent with the hypothesis that
rearward movement is due to a rigor-like binding of the Myo10
head domain to actin filaments undergoing retrograde flow.
Third, Myo10 can undergo retrograde movements on the
filopodial rootlets within lamellipodia, which demonstrates
that Myo10 is capable of localizing to portions of filopodia not
completely ensheathed by plasma membrane. Fourth, Myo10
was observed at the tips of intrapodia-like processes
undergoing ‘rocketing’ movements. Although this is the first
observation associating Myo10 with actin-based rocketing, like
that of Listeria, it is not unexpected given the overall
similarities between intrapodia (Rochlin et al., 1999) and
filopodia. Finally, full-length Myo10 localizes to the tips of
filopodia at sites of cell-substrate and cell-cell contact.
Although this might simply reflect the presence of full-length
Myo10 at the tips of virtually all filopodia, Myo10 can bind to
-integrins (Zhang et al., 2004) and filopodia are reported to
mediate certain forms of cell-cell contact (Vasioukhin et al.,
2000).
Lateral movements of Myo10 along the leading edge
and a role for Myo10 at filopodial tips
We have also identified a novel form of Myo10 movement, in
which puncta of Myo10 were shown to move laterally along
the leading edge of lamellipodia. Kymographic analysis shows
that these movements lead tip puncta to collide and undergo
lateral fusion events. The actin bundles and filopodial rootlets
of growth-cone lamellipodia have been observed to undergo
similar lateral movements, and these movements are
hypothesized to arise from the lateral pushing forces generated
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90° to the leading edge (Katoh et al., 1999a; Katoh et al.,
1999b; Oldenbourg et al., 2000). Our observation that small
puncta of Myo10 appear along the leading edge and eventually
fuse to form larger tip puncta demonstrates that puncta of
Myo10 are continuously being ‘born’ along the leading edge,
and that even large and apparently stable tip complexes are
actually dynamic structures. Since Myo10 localizes to the tips
of filopodial actin bundles – the sites of filopodial actin
polymerization – it is probable that Myo10 and the associated
filopodial tip complex function in this process. In this regard,
it should be noted that neuronal growth cones are reported to
have peripheral actin arrays with very prominent filopodial
actin bundles and relatively little ARP2/3 at their leading edge
(Strasser et al., 2004).
The lateral fusion events of Myo10 puncta in CAD cells also
appear closely related to ‘-precursors’ – the proposed sites of
filopodial initiation in the convergent elongation model
(Svitkina et al., 2003). -precursors form when actin filaments
at the leading edge move laterally, collide and associate at their
barbed ends to form -shaped structures that appear to initiate
filopodial actin bundles. Since puncta of Myo10 undergo
similar movements at the leading edge and form puncta at the
tips of actin bundles, Myo10 is probably a component of -
precursors and might thus be involved in filopodial initiation.
We have previously demontrated an important role for Myo10
in filopodia by showing that GFP-Myo10 can be detected at
the tips of filopodia as soon as they form, and by showing that
overexpression of Myo10 leads to increased numbers of
filopodia (Berg and Cheney, 2002).
In conclusion, we have shown here that brain expresses a
headless form of Myo10 that is developmentally regulated but
lacks motor activity and does not localize to filopodia. We have
also shown that full-length Myo10 undergoes novel forms of
movement in neuronal cells, but that headless Myo10 neither
localizes to filopodia nor undergoes these movements. These
results support the model that Myo10’s motor activity is
required for its tip localization and intrafilopodial motility. As
a molecular motor that binds integrins, Myo10 is also a strong
candidate to act as a molecular clutch, whose motor activity
can maintain its localization at the tips of growing actin
filaments, while its tail provides a link to the cytoplasmic
domains of substrate-attached cell-surface molecules.
Although the precise functions of headless Myo10 and
structurally similar proteins, such as MAX-1, are not yet clear,
the localization and dynamics of full-length Myo10 suggests
that it functions as a component of a filopodial-tip complex,
involved in processes such as filopodial extension and adhesion
in developing neurons.
Materials and Methods
Northern blotting and RT-PCR of a headless Myo10 transcript
Probes for northern blotting were generated by PCR. A 366 nt-long probe, specific
for full-length Myo10 corresponding to nucleotides 226-591 of human Myo10
cDNA NM_012334 was generated using forward primer 5-GATAACTT-
CTTCACCGAGGGAACAC and reverse primer 5-CCGGCTGTACTGCTCCAT-
GGTGGCAG. A 158 nt-long probe, specific for the putative 5UTR of headless
Myo10 corresponding to nucleotides 33-190 of human EST AI878891 was
generated using forward primer 5-CAGCACAGCCCGAGACGCAC and reverse
primer 5-CTTGGGTTTTCTTTCACCCCTTCAG. A ~1.1 kb probe corresponding
to nucleotides 6240-7330 of human Myo10 cDNA NM_012334 reacts with both
full-length- and headless-Myo10, as described in Berg et al. (Berg et al., 2000). The
human multiple tissue northern blot (Clontech) previously used with this probe was
stripped according to the manufacturer’s instructions and reprobed essentially as
described (Berg et al., 2000). 
Reverse transcription (RT)-PCR with Poly A+ mRNA from human brain
(Clontech) was used to verify the existence of the headless mRNA predicted by
sequence analysis. RT was performed using SuperScript II polymerase (Gibco)
according to the manufacturer’s instructions, with 1/10 of the RT reaction (2 l)
used for each PCR reaction. The forward primer 5-CAGCACAGCCCGA-
GACGCAC corresponds to nucleotides 33-55 of human EST AI878891, located
within the putative headless-specific exon that contains the alternative 5 UTR. The
reverse primer 5-CTCGCTGTTGGAGGCATCATAGA corresponds to nucleotides
2307-2370 of the full length Myo10, located 377 nucleotides downstream in a
protein-coding exon predicted to be present in both headless- and full-length-
Myo10. The 377 nt-long PCR product was purified from an agarose gel, cloned into
pCRII-TOPO (Invitrogen), and verified by sequencing.
Antibodies and plasmids
An antibody (no. 3568) to the coiled-coil region of mouse Myo10 was raised in
chicken as described below. The coiled-coil region (aa 808-918 of mouse Myo10
sequence NP_062345.1) was amplified by PCR using forward primer 5-
CGCGGATCCTACAGGCAGCTGTTGG and reverse primer 5-CCAAGCTTA-
CAGCTTCTGCAGGGA. The PCR product was subcloned into pQE-30 vector
(Qiagen) using restriction sites engineered into the PCR primers. The resulting 123
aa RGS-His tagged fusion protein was expressed in the XL1-blue strain of
Escherichia coli, solubilized in 20 mM Tris pH 8.0 with 500 mM NaCl buffer and
purified by two cycles of absorption-elution on Ni-NTA agarose resin (Qiagen)
followed by anion-exchange chromatography on Q-Sepharose Fast Flow resin
(Pharmacia). This fusion protein was injected into a chicken and the IgY from eggs
(Aves Labs) was purified on an affinity column consisting of the coiled-coil fusion
protein. Full-length GFP-Myo10 (aa 1-2052 of bovine Myo10 sequence U55042),
GFP-Myo10-HMM (aa 1-943) and a GFP-tagged construct corresponding to the
headless form of Myo10 (aa 644-2052) were generated in pEGFP-C2 as previously
described (Berg and Cheney, 2002).
Tissue samples and immunoblotting
To determine the developmental expression pattern of Myo10, brains from a litter
of C57/black mice were collected at different time points, dissected into cerebri and
cerebelli and frozen in liquid nitrogen until all time points had been collected.
Samples were homogenized in 10 ml/g of Lysis Buffer (1PBS with 5 mM DTT,
1 mM Pefabloc, 5 g/ml pepstatin A, 5 g/ml leupeptin, 2 mM EDTA, 0.2 mM
PMSF and 1% Sigma protease inhibitor cocktail cat. no. P-8440) and boiled
immediately in SDS sample buffer. Immunoblotting was performed as described
previously (Berg et al., 2000), except that 1 g/ml of Myo10 antibody no. 3568 was
used here.
Cell culture and transfection
CAD cells are a subclone of Cath-a cells that can be differentiated into a
catecholaminergic neuronal phenotype by serum withdrawl (Qi et al., 1997). CAD
cells were cultured in HAM-F12 with 8% fetal bovine serum (FBS) and 1%
penicillin/streptomycin as previously described (Wang and Oxford, 2000).
Undifferentiated CAD cells were transiently transfected at 60-80% confluence using
Polyfect (Qiagen) for 12 hours following to the manufacturer’s instructions for HeLa
cells. CAD cell differentiation was induced 1 day after transfection by 1-3 days of
serum withdrawal. Lysates were prepared by scraping cells in Lysis Buffer and
homogenizing on ice with ~75 strokes of a Dounce homogenizer.
Staining procedures
For immunofluorescence, CAD cells were plated onto coverslips that had been
coated with 20 g/ml laminin (Invitrogen). Cells were fixed with 4%
paraformaldehyde for 10 minutes, permeabilized with 0.2% Triton X-100 for 5
minutes, blocked with 5% heat-inactivated goat serum for 1 hour in PBS and washed
three times for 15 minutes in PBS. Coverslips were then incubated overnight at 4°C
with 1 g/ml of chicken anti-Myo10 antibody no. 3568 or chicken non-immune
IgG in PBS plus goat serum, rinsed three times in PBS, and incubated 1-3 hour at
room temperature with 0.5 g/ml goat anti-chicken secondary antibody (Molecular
Probes, no. A-11039) in PBS plus goat serum. Coverslips were then incubated with
1.5 nM rhodamine-phalloidin and 30 nM DAPI in PBS for 0.5 hour, washed three
times in PBS, and mounted in Gel/Mount (Biomeda).
30-m-thick cryo-sections of brain for immunofluorescence were obtained from
P70 mice, and were then perfused with 50 ml saline buffer and 50 ml 4%
paraformaldehyde followed by immersion at 4°C in 4% paraformaldehyde overnight
and 30% sucrose in 0.1 M phosphate buffer (pH 7.4) for 2-3 days. Floating sections
were permeabilized with three washes of PBSX (PBS plus 0.2% Triton X-100),
incubated 1 hour at room temperature in blocking buffer (PBSX plus 5% BSA and
1% goat serum; filtered through a 0.2 m filter) and incubated overnight at 4°C
with primary antibodies in blocking buffer. Chicken anti-Myo10 antibody no. 3568
and a non-immune chicken IgG control were used at 4 g/ml, whereas rabbit anti-
calbindin (Sigma, no. C-2724) and rabbit anti-GFAP (Chemicon no. AB5804) were
used at 1:500 dilution. Sections were washed three times with PBSX, incubated for
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at 8 g/ml in Blocking Buffer, washed three times with PBSX, and mounted with
Vectashield (Vector labs).
Imaging and analysis
Brain sections were imaged with a Zeiss Axioplan2 confocal microscope with a
BioRad Radiance 2000 scanning system using either a 10 or 1.4 NA 63 lens.
Cultured cells were imaged using a wide-field inverted microscope with a cooled
CCD and Metamorph software. Time-lapse images were acquired in phase and
fluorescence every 5 seconds for 3-60 minutes using exposure times of 100-600
mseconds at 37°C with a 60 1.4 NA lens. To separate CFP and GFP images in
double-labeled cells, images were captured using a Chroma 86006bs beamsplitter
with an excitation filter wheel (CFP: 431-441 nm; GFP: 483-501 nm) and an
emission filter wheel (CFP: 450-490 nm; GFP: 520-550 nm). Immunfluorescence
images and their corresponding controls were collected and scaled identically for
brightness and contrast with Metamorph or Adobe Photoshop. Kymographs of the
leading edge were generated with Metamorph to outline the edge of a cell and
plotting the maximum brightness-value from a line-width of 13 pixels.
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